Month: January 2018

Merck & Co., Inc. MRK announced that its anti-PD-1 therapy, Keytruda (pembrolizumab), has been approved in Japan for previously-treated patients with urothelial carcinoma, a type of bladder cancer. This approval makes Keytruda eligible to be indicated for four types of cancer in Japan. […]

On Jan 2, 2018, we issued an updated research report on leading medical devices company, Boston Scientific Corporation BSX . The stock carries a Zacks Rank #3 (Hold). Over the past three months, Boston Scientific has been trading below the broader industry on several issues. […]

On Jan 3, Pioneer Natural Resources Company PXD was raised to a Zacks Rank #1 (Strong Buy). Why the Upgrade? […]

Mondelez International, Inc. MDLZ has teamed up yet again with the third-largest cereal company in the United States, Post Consumer Brands, to create two cookie-inspired breakfast cereals. […]

ReneSola Ltd SOL has announced that it has successfully connected more than 90 megawatt (MW) of rooftop solar projects in China in the second half of 2017. Of the total rooftop projects, the company intends to let out nearly 20 MW toward Engineering, Procurement, and Construction (EPC) services and will hold on to the remaining 70 MW. […]

WEC Energy Group WEC is gaining from ongoing improvements in economic conditions in service territories. The company is currently serving more customers than the year-ago level. Further, the planned long-term investments in infrastructure projects are anticipated to aid in meeting the increasing customer demand, as it continues to improve service reliability. […]

The New Year brought favorable tidings to the employees of airline heavyweights, American Airlines Group AAL and Southwest Airlines LUV , as the carriers announced bonuses worth $1,000 per member, following the tax overhaul. Notably, the $1.5 trillion tax overhaul package signed into law by President Trump reduces corporate taxes from 35% to 21%. European low-cost carrier, Ryanair Holdings RYAAY , also grabbed headlines when it released impressive traffic data for December, 2017. […]

The Boston Beer Company ’s SAM stellar performance in the past few months clearly portrays the credibility of its three-point growth plan. This plan mainly focuses on revival of its Samuel Adams and Angry Orchard brands, cost saving initiatives and long-term innovation programs. Further, the company’s continuous efforts to offset the persistent softness in depletion trends have helped it sustain amid the tough competitive scenario […]

The year 2017 witnessed a lot of regulatory noise surrounding the Affordable Care Act (ACA). Also, health insurers scaled back their participation due to continued loss on public exchanges. Rising consolidation was another major issue […]

A recreational vehicle (RV) is a motor vehicle equipped with amenities available at home. RVs are designed for recreational purpose, much like camping. Per a Global Industry Analysts report, growing passion for “great outdoors” and fondness for “adventure travel” is leading to robust growth in the global RV market. […]

In 2017, oil prices recovered significantly. Posting its second annual gain in a row, the commodity closed 2017 up more than 12%. […]

Intercontinental Exchange Group Inc . ICE is poised for growth, given its strength in global data services, diverse liquid, global derivatives and equities markets across 12 exchanges, six clearing houses and nine asset classes. This Zacks Rank #2 (Buy) exchange operator remains promising, banking on several growth prospects. […]

Continuing with the efforts of streamlining its portfolio in order to offer the best investment solutions to clients, The Bank of New York Mellon Corporation ’s BK investment management division has completed the sale of CenterSquare Investment Management to its management team and the private equity firm Lovell Minnick Partners. However, terms of the deal have yet to be disclosed. Being an investment manager that primarily focuses on managing real estate and infrastructure strategies, CenterSquare manages investments for institutional investors and high net worth individuals […]

Bank of the Ozarks OZRK announced a 2.7% hike in its quarterly cash dividend. The new dividend of 19 cents per share will be paid on Jan 26 to shareholders on record as of Jan 19. This is the 30th consecutive quarterly increase in dividend by the bank […]

Seattle Genetics, Inc. SGEN announced today that the FDA has accepted for filing a supplemental Biologics License Application (sBLA) for the label expansion of its lymphoma drugAdcetris (brentuximab vedotin) and granted priority review. The sBLA is filed for Adcetris in combination with chemotherapy for the frontline treatment of patients with advanced classical Hodgkin lymphoma. […]

AngioDynamics Inc. ANGO is set to report second-quarter fiscal 2018 results on Jan 4, before market opens. […]